ARTICLE | Company News
Opalia Pharma S.A., Recordati deal
June 9, 2014 7:00 AM UTC
Recordati completed its acquisition of 90% of branded generics company Opalia. Specifically, Recordati acquired 23% of Opalia shares for about €5.9 million ($8 million). In October, Recordati acquired...